Summary

Global Biopharma Plastics Market is valued at approximately USD 4.34 billion in 2021 and is anticipated to grow with a healthy growth rate of more than 11.2% over the forecast period 2022-2029. Biopharma plastics are specially designed plastics that plays important role in maintaining the characteristics of the drugs and product quality owing to their properties of high resistivity, low chemical reactivity, and thermal stability. Biopharma plastics are gaining high traction in the production of various healthcare products including containers, disposable connectors, syringes, protective wear, and bioreactor bags. The rising expenditure on healthcare products and services, increasing demand for biopharma plastics polymers, coupled with the growing awareness regarding maintaining a hygienic and clean environment at healthcare facilities are key factors that are bolstering market growth globally.

The rising prevalence of a wide range of medical illnesses among the geriatric population is exhibiting a positive influence on the market demand across the globe. The United Nation reported that it was estimated that there were 703 million persons aged 65 years or over in the world in 2019, which is projected to double to 1.5 billion by 2050. The rapidly growing ageing people are more prone to be affected by a variety of diseases and disorders, which is propelling the need for better healthcare facilities and treatments. Thereby, the escalating geriatric population and consequential medical treatments are reinforcing the demand for biopharma plastics, which is fueling the growth of the market. Moreover, the rising adoption of advanced healthcare technologies, as well as high potential in developing economies are presenting various lucrative opportunities over the forecasting years. However, the fluctuation in the prices of raw materials and the imposition of stringent norms are challenging the market growth throughout the forecast period of 2022-2029.

The key regions considered for the Global Biopharma Plastics Market study include Asia Pacific, North America, Europe, Latin America, and the Rest of the World. The Asia Pacific dominated the market in terms of revenue, owing to the surging demand for high-quality biopharma plastic devices and components, the development of emerging economies, along the increasing healthcare expenditure. Whereas, North America is expected to grow with the highest CAGR during the forecast period, owing to factors such as the rising focus on the advancement of healthcare services and the presence of the leading industry players in the market space.

Major market players included in this report are:
BASF SE
LyondellBasell Industries Holdings B.V.
LG Chem Ltd.
Toray Industries, Inc.
Dow, Inc.
DuPont de Nemours, Inc.
Chevron Phillips Chemical Co., LLC
Exxon Mobil Corporation
Formosa Plastics Corporation
Covestro AG

Recent Developments in the Market:
 In October 2021, DuPont unveiled the introduction of its new DuPont Liveo pharma bottle closures that are made from biomedical-grade silicone elastomer. The product is specially designed to seal plastic bottles and threaded glass containers that are adopted for media, critical fluid transfer, buffer pooling and storage, and sample collection in biopharmaceutical and biotechnology processes.
 In June 2021, Celanese Corporation declared that the company acquire a contractual deal with the aim of attaining Exxon Mobil Corporation's Santoprene TPV elastomers division. Santoprene TPV materials are adopted in biopharma, healthcare, and medical devices such as peristaltic tubes, syringe tips, seals, dental, tourniquets, prosthetic cushions, medical hoods, and masks.




Global Biopharma Plastics Market Report Scope:
Historical Data 2019-2020-2021
Base Year for Estimation 2021
Forecast period 2022-2029
Report Coverage Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
Segments Covered Polymer Type, Application, , Region
Regional Scope North America; Europe; Asia Pacific; Latin America; Rest of the World
Customization Scope Free report customization (equivalent up to 8 analyst’s working hours) with purchase. Addition or alteration to country, regional & segment scope*




The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Polymer Type:
Polyethylene (PE)
Polypropylene (PP)
Acrylonitrile Butadiene Styrene (ABS)
Polyethylene Terephthalate (PET)
Polyvinyl Chloride (PVC)
Polytetrafluoroethylene (PTFE)
Other
By Application:
Protective Wear
Containers
Syringes
Disposable Medical Connectors
Others

By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
RoLA
Rest of the World

ページTOPに戻る

Table of Contents

Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Billion)
1.2.1. Biopharma Plastics Market, by Region, 2019-2029 (USD Billion)
1.2.2. Biopharma Plastics Market, by Polymer Type, 2019-2029 (USD Billion)
1.2.3. Biopharma Plastics Market, by Application, 2019-2029 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Biopharma Plastics Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Biopharma Plastics Market Dynamics
3.1. Biopharma Plastics Market Impact Analysis (2019-2029)
3.1.1. Market Drivers
3.1.1.1. Increasing demand for biopharma plastics polymers
3.1.1.2. Increasing geriatric population and consequential medical treatments
3.1.2. Market Challenges
3.1.2.1. Fluctuation in the prices of raw materials
3.1.2.2. Imposition of stringent norms
3.1.3. Market Opportunities
3.1.3.1. Rising adoption of advanced healthcare technologies
3.1.3.2. High potential in developing economies
Chapter 4. Global Biopharma Plastics Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. Futuristic Approach to Porter’s 5 Force Model (2019-2029)
4.3. PEST Analysis
4.3.1. Political
4.3.2. Economical
4.3.3. Social
4.3.4. Technological
4.4. Top investment opportunity
4.5. Top winning strategies
4.6. Industry Experts Prospective
4.7. Analyst Recommendation & Conclusion
Chapter 5. Risk Assessment: COVID-19 Impact
5.1. Assessment of the overall impact of COVID-19 on the industry
5.2. Pre COVID-19 and post COVID-19 Market scenario
Chapter 6. Global Biopharma Plastics Market, by Polymer Type
6.1. Market Snapshot
6.2. Global Biopharma Plastics Market by Polymer Type, Performance - Potential Analysis
6.3. Global Biopharma Plastics Market Estimates & Forecasts by Polymer Type 2019-2029 (USD Billion)
6.4. Biopharma Plastics Market, Sub Segment Analysis
6.4.1. Polyethylene (PE)
6.4.2. Polypropylene (PP)
6.4.3. Acrylonitrile Butadiene Styrene (ABS)
6.4.4. Polyethylene Terephthalate (PET)
6.4.5. Polyvinyl Chloride (PVC)
6.4.6. Polytetrafluoroethylene (PTFE)
6.4.7. Other

Chapter 7. Global Biopharma Plastics Market, by Application
7.1. Market Snapshot
7.2. Global Biopharma Plastics Market by Application, Performance - Potential Analysis
7.3. Global Biopharma Plastics Market Estimates & Forecasts by Application 2019-2029 (USD Billion)
7.4. Biopharma Plastics Market, Sub Segment Analysis
7.4.1. Protective Wear
7.4.2. Containers
7.4.3. Syringes
7.4.4. Disposable Medical Connectors
7.4.5. Others
Chapter 8. Global Biopharma Plastics Market, Regional Analysis
8.1. Biopharma Plastics Market, Regional Market Snapshot
8.2. North America Biopharma Plastics Market
8.2.1. U.S. Biopharma Plastics Market
8.2.1.1. Polymer Type breakdown estimates & forecasts, 2019-2029
8.2.1.2. Application breakdown estimates & forecasts, 2019-2029
8.2.2. Canada Biopharma Plastics Market
8.3. Europe Biopharma Plastics Market Snapshot
8.3.1. U.K. Biopharma Plastics Market
8.3.2. Germany Biopharma Plastics Market
8.3.3. France Biopharma Plastics Market
8.3.4. Spain Biopharma Plastics Market
8.3.5. Italy Biopharma Plastics Market
8.3.6. Rest of Europe Biopharma Plastics Market
8.4. Asia-Pacific Biopharma Plastics Market Snapshot
8.4.1. China Biopharma Plastics Market
8.4.2. India Biopharma Plastics Market
8.4.3. Japan Biopharma Plastics Market
8.4.4. Australia Biopharma Plastics Market
8.4.5. South Korea Biopharma Plastics Market
8.4.6. Rest of Asia Pacific Biopharma Plastics Market
8.5. Latin America Biopharma Plastics Market Snapshot
8.5.1. Brazil Biopharma Plastics Market
8.5.2. Mexico Biopharma Plastics Market
8.5.3. Rest of Latin America Biopharma Plastics Market
8.6. Rest of The World Biopharma Plastics Market

Chapter 9. Competitive Intelligence
9.1. Top Market Strategies
9.2. Company Profiles
9.2.1. BASF SE
9.2.1.1. Key Information
9.2.1.2. Overview
9.2.1.3. Financial (Subject to Data Availability)
9.2.1.4. Product Summary
9.2.1.5. Recent Developments
9.2.2. LyondellBasell Industries Holdings B.V.
9.2.3. LG Chem Ltd.
9.2.4. Toray Industries, Inc.
9.2.5. Dow, Inc.
9.2.6. DuPont de Nemours, Inc.
9.2.7. Chevron Phillips Chemical Co., LLC
9.2.8. Exxon Mobil Corporation
9.2.9. Formosa Plastics Corporation
9.2.10. Covestro AG
Chapter 10. Research Process
10.1. Research Process
10.1.1. Data Mining
10.1.2. Analysis
10.1.3. Market Estimation
10.1.4. Validation
10.1.5. Publishing
10.2. Research Attributes
10.3. Research Assumption